🟢 Cue Biopharma is trading 5.57% up in pre-market amid broader risk-on rebound

Cue Biopharma is trading 5.57% up in pre-market at $25.98, appearing to reflect broader pre-market risk appetite after the previous session’s selloff.

• Nasdaq futures are up 0.61%.
• The stock closed at $24.61 on August 20, 2026.
• No new company-specific announcement was found for August 21; the latest listed release was the August 3 CFO appointment and CUE-221 IND submission. Insider-sale disclosures are dated August 12–13.